Search Results 471-480 of 18239 for Immunode

1. DiGeorge syndrome (22q11.2 deletion syndrome) - Symptoms and causes - Mayo Clinic

   DiGeorge syndrome (DGS). American Academy of Allergy Asthma & Immunology. https://www.aaaai.org/conditions-treatments/primary-immunodeficiency-disease/digeorge- ...

2. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrent C. Diff - Mayo Clinic

   Compromised immune system, including, but not limited to, a known history of human immunodeficiency virus infection and cluster of differentiation 4 count ...

3. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

   Known human immunodeficiency virus (HIV) infection. Exposed to live or live attenuated vaccine within 4 weeks prior to signing ICF. Pregnancy or breast ...

4. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   History of symptomatic deep vein thrombosis or pulmonary embolism within 6 months of enrollment. Primary immunodeficiency; Known infection with HIV ...

5. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   Has a known history of active primary immunodeficiency, uncontrolled active HIV infection with serologic evidence of viral infection within 28 days of C1D1.

6. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   Patients who are Human Immunodeficiency Virus (HIV) positive are eligible if they have undetectable HIV viral load and CD4+ T-cell count ≥ 250/mm^3.

7. A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 - Mayo Clinic

   History or presence of hepatitis B (surface antigen positivity), active hepatitis C or human immunodeficiency virus (HIV) antibody; Active infection within ...

8. MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) - Mayo Clinic

   * Has hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection * History of active malignancy within 3 years prior to screening * RNA ...

9. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   Participant is: known history of human immunodeficiency virus (HIV); Seropositive for hepatitis B (defined by a positive test for hepatitis B surface ...

10. BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma - Mayo Clinic

    Clinically relevant active infection including active hepatitis B or C or human immunodeficiency virus (HBV, HCV, or HIV) or any other concurrent disease ...